Y4C-99024-73945
3 vaccinations
3 coded responses
20 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 950 / CA
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- N/A
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Moderna
- 2020-12-29
- 2020-12-30
-
2020-12-31
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-06
-
2021-01-12
Survey response — day 14, dose 1MedDRA: Injection site erythema, Injection site pruritus, Injection site swelling — Feeling: GoodFree text: Mild- Redness to injection site, mild itchiness, and swellingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-19
-
2021-01-26
Dose 2 — Moderna
-
2021-02-02
Health check-in — day 7, dose 2Feeling: Good · Site: Redness, Swelling, Itching · HeadacheAdult check-in
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-04-27
-
2021-11-02
Dose 3 — Moderna
-
2022-01-26
Survey response — 12 months, dose 2MedDRA: Headache, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Headache, runny nose, and congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-05-03
-
2022-11-07
Survey response — 12 months, dose 3MedDRA: Influenza, Pneumonia, Staphylococcal infection — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Influenza, pneumonia, and mrsaMedDRA releases: 2024-11 · check-in free text available
-
2022-11-07
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-11-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Moderna | |
| 2 | 2021-01-26 | Moderna | |
| 3 | 2021-11-02 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-11-07 | Unsuccessful |
Free text
Release 1 — day 14, dose 1
Symptoms: Mild- Redness to injection site, mild itchiness, and swelling
Release 11 — 12 months, dose 2
Symptoms: Headache, runny nose, and congestion
Release 12 — 12 months, dose 3
Symptoms: Influenza, pneumonia, and mrsa
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Pneumonia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Staphylococcal infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release